NCT04760301 Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
| NCT ID | NCT04760301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meir Medical Center |
| Condition | Blood Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2021-02-16 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2021-02-16 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Eligibility Criteria
Inclusion Criteria: * 20-90 years old female patients going through vaginal hysterctomy Exclusion Criteria: * massive bleeding during operation due to major vessles injury * known coagulopathies * sensitivity to tranexamic acid * medical need in tranexamic acid administration during operation due to bleeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04760301 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 90 Years, studying Blood Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04760301 currently recruiting?
Yes, NCT04760301 is actively recruiting participants. Contact the research team at yair.dykan@gmail.com for enrollment information.
Where is the NCT04760301 trial being conducted?
This trial is being conducted at Kfar Saba, Israel, Kfar Saba, Israel.
Who is sponsoring the NCT04760301 clinical trial?
NCT04760301 is sponsored by Meir Medical Center. The trial plans to enroll 60 participants.